|
Erectile Dysfunction News |
|
Erectile Dysfunction / Premature Ejaculation News From Medical News Today
|
Latest Erectile Dysfunction / Premature Ejaculation News From Medical News Today.
|
-
Maxi-K Gene Transfer May Prove To Be Safe And Effective Erectile Dysfunction Treatment
Maxi-K gene therapy may be a safe and effective future option for men whose erectile dysfunction (ED) is not treatable with oral therapy. Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA) may give hope to these individuals. Researchers will present their findings to reporters in a special press conference on May 20, 2008 at 10 a.m.
-
Definition Of Premature Ejaculation By International Society For Sexual Medicine (ISSM)
Despite the fact that it has long been a major concern for men, an evidence-based definition for premature ejaculation has not existed until now. In October 2007, the International Society for Sexual Medicine (ISSM) gathered the world's leading sexual health experts to develop an evidence-based definition of premature ejaculation. Experts will present the definition to reporters in a special press conference on May 19th at Monday, May 19, 2008 at 10:00 a.m.
-
Erectile Dysfunction After External Beam Radiotherapy For Prostate Cancer
UroToday.com - Currently, the most common curative treatment options for men with localized prostate cancer are radical prostatectomy, external beam radiotherapy and interstitial permanent brachytherapy and radical prostatectomy. Treatment decisions should particularly consider the specific risk and toxicity profile of a treatment method.
-
New Penile Pump Could Improve Patient Satisfaction, Confidence
Erectile dysfunction (ED) has a dramatic impact on quality of life. Treatments for ED continue to improve, and penile prostheses have one of the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Susanne A. Quallich, Dana A. Ohl and Rodney L. Dunn survey urologic health care practitioners to find the penile prosthesis pump that is easiest to use and teach to patients.
-
Teaching Patients To Use Their Penile Prosthesis Requires Compassion
While penile prosthesis devices are the most invasive and least chosen treatments for erectile dysfunction (ED), the devices garner the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Annette Liechty and Susanne A. Quallich review a teaching process that nurses can use to show a patient to successfully operate the device.
-
Fewer Complications From Minimally Invasive Pancreas Surgery
When surgeons need to remove part of the pancreas, performing the operation with minimally invasive techniques offers patients a shorter hospital stay and fewer complications, researchers have concluded.A study of more than 660 operations to remove pancreatic tumors and cysts over five years found that after laparoscopic surgery, patients stayed a third less time in the hospital without experiencing more complications such as leaks.
-
Correlation Between Erectile Dysfunction And LUTS The AUA Lecture
UroToday.com - Dr. Kevin McVary (Chicago) presented the AUA lecture. The incidence of ED increases to over 60% by age 60. He showed data that ED increases with increasing severity of LUTS, independent of age. Across all age groups, increasing LUTS correlated with worse ED even after adjusting for other factors such as diabetes mellitus. This suggests a common pathophysiology or causal relationship between ED and LUTS.
-
Federal Authorities Seize More Than 100,000 Dollars Of Unapproved Drugs Marketed As "Natural Supplements"
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized more than 14,000 dosage units of Shangai Regular, Shangai Ultra, Super Shangai, Naturalë Super Plus, and Lady Shangai. Although labeled as natural supplements, the seized products were all marketed to treat erectile dysfunction (ED), impotency, and/or to provide sexual enhancement, which caused them to be drugs under the Federal Food, Drug, and Cosmetic Act.
-
VIVUS Enters Into 30 Million Dollars Funding Collaboration For The Phase 3 Studies Of Avanafil For Erectile Dysfunction
VIVUS, Inc. (NASDAQ: VVUS) announced that it has entered into a $30 million funding collaboration with Deerfield Management ("Deerfield"). Under the terms of the agreements, Deerfield will provide funds for the phase 3 program for avanafil, a fast-acting, highly selective, phosphodiesterase type 5 inhibitor (PDE5i) for the treatment of erectile dysfunction (ED).
-
Levitra® Therapy Suitable For Men With High Cholesterol
At the 23rd Annual European Association of Urology (EAU) Congress, results were presented which added evidence that Levitra® (vardenafil HCI) works very well in men with dyslipidemia.(1) The double-blind, placebo-controlled trial in about 400 men showed that Levitra® significantly improved the ability of men with erectile dysfunction (ED) and high cholesterol, to achieve and maintain an erection for successful sexual intercourse.(2) The trial, led by Dr.
|
|
News & Information 
